Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Chulalongkorn University
Queen Savang Vadhana Memorial Hospital, Thailand
Information provided by (Responsible Party):
Thai Red Cross AIDS Research Centre
ClinicalTrials.gov Identifier:
NCT00872872
First received: March 30, 2009
Last updated: January 17, 2017
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2025
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)